FAM177A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.63880020664919E-12 |
Normal-vs-Stage2 |
1.1634027075047E-11 |
Normal-vs-Stage3 |
2.4871999999565E-06 |
Normal-vs-Stage4 |
3.15740000034204E-07 |
Stage1-vs-Stage2 |
3.483200E-01 |
Stage1-vs-Stage3 |
6.565700E-02 |
Stage1-vs-Stage4 |
8.410600E-01 |
Stage2-vs-Stage3 |
3.332400E-02 |
Stage2-vs-Stage4 |
6.141200E-01 |
Stage3-vs-Stage4 |
2.327200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62669877568078E-12 |
Normal-vs-AfricanAmerican |
2.33146835171283E-13 |
Normal-vs-Asian |
3.223500E-04 |
Caucasian-vs-AfricanAmerican |
8.895000E-01 |
Caucasian-vs-Asian |
7.822200E-01 |
AfricanAmerican-vs-Asian |
7.330200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62503344114384E-12 |
Normal-vs-Female |
1.72561964717488E-12 |
Male-vs-Female |
7.249400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.04236627610044E-12 |
Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
Normal-vs-Obese |
1.1348999517935E-10 |
Normal-vs-Extreme_Obese |
8.424900E-03 |
Normal_Weight-vs-Extreme_Weight |
7.632600E-01 |
Normal_Weight-vs-Obese |
1.693410E-01 |
Normal_Weight-vs-Extreme_Obese |
2.581200E-01 |
Extreme_Weight-vs-Obese |
1.676970E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.286200E-01 |
Obese-vs-Extreme_Obese |
7.956200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.636330E-03 |
Normal-vs-Age(41-60Yrs) |
1.8961499037573E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.20599999997584E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.822600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.664650E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.758000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.653600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.518600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.608620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
Normal-VS-Type2 PRCC |
3.46100004211536E-09 |
Normal-VS-KIRP CIMP |
3.612100E-02 |
Normal-VS-Unclassified PRCC |
1.7178480860025E-12 |
Type1 PRCC-VS-Type2 PRCC |
4.356000E-03 |
Type1 PRCC-VS-KIRP CIMP |
2.013000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.286200E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.068200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.460800E-03 |
KIRP CIMP-VS-Unclassified PRCC |
1.540240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.67340030721164E-10 |
Normal-vs-N1 |
1.198020E-04 |
Normal-vs-N2 |
2.14229999961901E-07 |
N0-vs-N1 |
2.150800E-01 |
N0-vs-N2 |
1.997650E-01 |
N1-vs-N2 |
6.134200E-02 |
|
|